Meta-analysis of the robustness of COVID-19 diagnostic kit performance during the early pandemic.
Chandrakumar ShanmugamMichael BehringVishwas LuthraSixto M LealSooryanarayana VaramballyGeorge J NettoUpender MannePublished in: BMJ open (2022)
The robustness of the assays/platforms is influenced by variability in sampling and reagents. Serological testing complements and may minimise false negative RT-PCR results. Lack of standardised assay protocols in the early phase of pandemic might have contributed to the spread of COVID-19.